Otajonova Nazokat, Martinez Eric J, Gupta Amar, Bayer Johanna, Testa Giuliano, Wall Anji E
Department of General Surgery, Yale New Haven Health, New Haven, Connecticut, USA.
Annette C. and Harold C. Simmons Transplant Institute, Abdominal Transplant, Baylor Scott & White Health, Dallas, Texas, USA.
Proc (Bayl Univ Med Cent). 2025 Feb 5;38(3):253-258. doi: 10.1080/08998280.2025.2457899. eCollection 2025.
Donation after circulatory death (DCD) increased in the US over the past decade. However, 30% of DCD liver grafts procured for transplantation are not utilized. Barriers to DCD liver utilization include quality concerns, particularly the risk of ischemic cholangiopathy and retransplantation, and costs associated with DCD organ acquisition. This study investigated the attitudes of the liver transplantation community in the US toward DCD and identified barriers to DCD liver utilization.
RedCap survey of liver transplantation surgical directors in the US.
Of 101 liver transplantation surgical directors, 24 responded to the survey, and 96% of respondents accepted DCD donors. Most programs accepted livers from thoracoabdominal normothermic regional perfusion with cold storage (96%), while substantially fewer accepted liver grafts from rapid recovery DCD donors with cold storage (67%). Sixty-five percent of transplant centers' functional warm ischemic time started when oxygen saturation or systolic blood pressure was <80%/mm Hg; 13% started at extubation, 17.4% started at systolic blood pressure <80 mm Hg, and 4.3% used a systolic blood pressure <50 mm Hg.
We found variability among transplant programs in DCD liver graft acceptance based on procuring surgeon, procurement technique, and storage modality. Quality and cost are two main barriers to DCD liver utilization, with the main tradeoffs being between rapid recovery with static cold storage (lower cost, lower quality) and machine perfusion/normothermic regional perfusion (higher cost, better quality).
在过去十年中,美国循环死亡后器官捐献(DCD)有所增加。然而,用于移植的DCD肝移植器官中有30%未被利用。DCD肝利用的障碍包括质量问题,尤其是缺血性胆管病和再次移植的风险,以及与DCD器官获取相关的成本。本研究调查了美国肝移植界对DCD的态度,并确定了DCD肝利用的障碍。
对美国肝移植外科主任进行RedCap调查。
在101名肝移植外科主任中,24人回复了调查,96%的受访者接受DCD供体。大多数项目接受来自胸腹常温区域灌注加冷藏的肝脏(96%),而接受快速恢复DCD供体加冷藏的肝移植器官的项目则少得多(67%)。65%的移植中心在血氧饱和度或收缩压<80%/mmHg时开始计算功能性热缺血时间;13%在拔管时开始,17.4%在收缩压<80mmHg时开始,4.3%使用收缩压<50mmHg。
我们发现,根据获取外科医生、获取技术和储存方式的不同,移植项目在接受DCD肝移植器官方面存在差异。质量和成本是DCD肝利用的两个主要障碍,主要的权衡在于静态冷藏快速恢复(成本低、质量低)和机器灌注/常温区域灌注(成本高、质量好)之间。